Traing Source
Video: Compound Annual Growth Rate (CAGR) Definition


If the video does not load after a few moments, Upgrade to the Latest Flash Player.
Date Open High Low Close Volume
01/24/2018 $25.04 $25.41 $24.30 $24.64 296.60K
01/25/2018 $24.90 $25.02 $23.68 $24.61 386.80K
01/26/2018 $24.82 $25.00 $24.25 $24.53 277.80K
01/29/2018 $24.51 $24.95 $23.35 $23.61 398.20K
01/30/2018 $23.31 $23.32 $22.47 $22.57 284.20K
Aclaris Therapeutics is a clinical-stage biotechnology company focused on identifying, developing and commercializing drugs to address the needs in dermatology. Co.'s primary drug candidate, A-101 40% Topical Solution, is a formulation of high-concentration hydrogen peroxide topical solution that Co. is developing as a prescription treatment for seborrheic keratosis, a non-malignant skin tumor. Co. is also developing A-101 45% Topical Solution as a prescription treatment for common warts, also known as verruca vulgaris. Co. in-licensed rights to certain inhibitors of the Janus kinase family of enzymes, for specified dermatological conditions, including alopecia areata, and vitiligo.
ACRS historical stock prices picture
Aclaris Therapeutics (ACRS) has the following price history information. Looking back at ACRS historical stock prices for the last five trading days, on January 24, 2018, ACRS opened at $25.04, traded as high as $25.41 and as low as $24.30, and closed at $24.64. Trading volume was a total of 296.60K shares. On January 25, 2018, ACRS opened at $24.90, traded as high as $25.02 and as low as $23.68, and closed at $24.61. Trading volume was a total of 386.80K shares. On January 26, 2018, ACRS opened at $24.82, traded as high as $25.00 and as low as $24.25, and closed at $24.53. Trading volume was a total of 277.80K shares. On January 29, 2018, ACRS opened at $24.51, traded as high as $24.95 and as low as $23.35, and closed at $23.61. Trading volume was a total of 398.20K shares. On January 30, 2018, ACRS opened at $23.31, traded as high as $23.32 and as low as $22.47, and closed at $22.57. Trading volume was a total of 284.20K shares.

ACRS Historical Stock Prices By Date:

ACRS historical cagr picture

Below, we examine the compound annual growth rate — CAGR for short — of an investment into Aclaris Therapeutics shares, starting with a $10,000 purchase of ACRS, and working forward through the historical stock price information to today.

Growth of $10,000.00
Without Dividends Reinvested

Start date: 10/06/2015
End date: 01/30/2018
Start price/share: $11.00
End price/share: $22.57
Dividends collected/share: $0.00
Total return: 105.18%
Average Annual Total Return: 36.30%
Starting investment: $10,000.00
Ending investment: $20,516.54
Years: 2.32
Date Close
01/24/2018$24.64
01/25/2018$24.61
01/26/2018$24.53
01/29/2018$23.61
01/30/2018$22.57
ACRS is categorized under the Healthcare sector; below are some other companies in the same sector:

ACRX Historical Stock Prices
ACST Historical Stock Prices
ACUR Historical Stock Prices
ADAP Historical Stock Prices
ADHD Historical Stock Prices
ADK Historical Stock Prices
ADMA Historical Stock Prices
ADMP Historical Stock Prices
ADMS Historical Stock Prices
ADPT Historical Stock Prices

ACRS Historical Stock Prices | | Copyright © 2013 - 2018, All Rights Reserved

Nothing in is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. Split history database is not guaranteed to be complete or free of errors. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following . Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; , and .